Related Experiment Video

Updated: Aug 2, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

Beneficial effects of statins in patients with non-ischemic heart failure

U Laufs1, S Wassmann, S Schackmann

  • 1Klinik und Poliklinik Innere Medizin III, Universität des Saarlandes, 66424 Homburg, Germany. ulrich@laufs.com

Zeitschrift Fur Kardiologie
|February 14, 2004
PubMed

Insights

Statins improved quality of life and exercise capacity in heart failure patients. This study suggests statins are a promising treatment strategy for heart failure, offering cholesterol-independent benefits.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • HMG CoA reductase inhibitors (statins) possess cholesterol-independent effects, including potential antihypertrophic actions on the heart.
  • The therapeutic role of statins in heart failure management remains largely unexplored.

Purpose of the Study:

  • To investigate the efficacy of statins as a novel treatment strategy for heart failure.
  • To evaluate the impact of statins on quality of life, exercise capacity, and cardiac function in patients with non-ischemic cardiomyopathy.

Main Methods:

  • A double-blind, randomized study involving 15 patients with heart failure (NYHA II-III) due to non-ischemic dilated cardiomyopathy.
  • Patients received either 0.4 mg cerivastatin or placebo for an average of 20 weeks.
  • Outcomes assessed included quality of life (Minnesota Living with Heart Failure Questionnaire), exercise capacity (6 min walking test), left ventricular ejection fraction, endothelial function, and inflammatory markers.

Main Results:

  • Significant improvements in quality of life and exercise capacity were observed in the statin group compared to placebo.
  • A trend towards increased left ventricular ejection fraction and improved endothelial function was noted with statin treatment.
  • Statins led to decreased plasma concentrations of troponin T, high-sensitivity C-reactive protein (hsCRP), plasminogen activator inhibitor-1 (PAI-1), and tumor necrosis factor alpha (TNFalpha).

Conclusions:

  • Statins demonstrate beneficial effects in patients with non-ischemic cardiomyopathy.
  • Statin therapy improves quality of life and exercise capacity in heart failure patients.
  • These findings suggest statins represent a promising novel treatment strategy for heart failure.
Abstract

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...